Clinical Trial Update: Post Approval Study of the CyPass System [NA]

View source ↗

Summary

Post-approval study of the CyPass System has terminated; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract
• Open-angle Glaucoma

Drugs mentioned

• CyPass System

Snippet

Sponsor: Alcon Research | Conditions: Primary Open-angle Glaucoma, Cataract | NA | Status: TERMINATED | Results posted: 2022-09-21